Alchemab Therapeutics is a clinical-stage biotech discovering protective antibodies from disease-resilient individuals to develop novel therapeutics.
Create a free EquityFlow account to see Alchemab Therapeutics's 1 funding round, 1 investors, 12 similar companies.
Sign up free → Sign in